News Pfizer's Arena buyout looks canny, as etrasimod aces phase 3... Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceu
News Flush with COVID cash, Pfizer tables $6.7bn bid for Arena Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etras
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
